大鼠galectin-9基因重組腺病毒載體的構建和鑒定_《中國普外基礎與臨床雜志》

作者：

李來邦 , 李立 , 冉江華 , 趙永恒 , 張升寧 , 劉靜 , 李鑄 , 蔣益舟

昆明市第一人民醫院暨昆明醫學院附屬甘美醫院肝膽胰一科，云南省器官移植研究所肝移植研究中心(云南昆明 650011);

關鍵詞：

大鼠 galectin9 基因克隆腺病毒載體 RT-PCR

視頻：

導出 下載 收藏 掃碼 引用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

目的克隆大鼠galectin-9基因全長cDNA，構建含大鼠galectin-9基因的重組腺病毒載體，并予以鑒定。方法從大鼠的肝臟組織中用RT-PCR的方法克隆擴增大鼠galectin-9基因，再定向插入到帶NotⅠ和HindⅢ酶切的pDC316-GFP穿梭質粒中，獲得穿梭質粒pDC316-GFP-galectin-9。經PCR、NotⅠ和HindⅢ酶切及測序鑒定后，用脂質體將穿梭質粒pDC316-GFP-galectin-9與腺病毒骨架質粒pBHGlox△E1.3Cre共轉染HEK-293細胞。經位點特異性重組獲得含目的基因的重組腺病毒Ad5-galectin-9，行PCR鑒定，經HEK-293細胞擴增及純化制備高滴度病毒液，用細胞培養方法測定病毒TCID50滴度。結果 PCR、酶切及測序證實穿梭質粒構建正確，PCR鑒定證實大鼠galectin-9基因重組腺病毒載體構建正確，病毒的感染滴度為1.4×109 U/ml。結論成功構建了含大鼠galectin-9基因的重組腺病毒表達載體，為進一步研究大鼠galectin-9基因的功能奠定了基礎。

引用本文： 李來邦,李立,冉江華,趙永恒,張升寧,劉靜,李鑄,蔣益舟. 大鼠galectin-9基因重組腺病毒載體的構建和鑒定. 中國普外基礎與臨床雜志, 2011, 18(2): 131-136. doi: 復制

1.	Hsu DK, Liu FT. Regulation of cellular homeostasis by galectins [J]. Glycoconj J, 2004, 19(79): 507515.
2.	Rabinovich GA, Toscano MA, Ilarregui JM, et al. Shedding light on the immunomodulatory properties of galectins: novel regulators of innate and adaptive immune responses [J]. Glycoconj J, 2004, 19(79): 565573.
3.	Wang F, He W, Zhou H, et al. The Tim3 ligand galectin9 negatively regulates CD8+ alloreactive T cell and prolongs survival of skin graft [J]. Cell Immunol, 2007, 250(12): 6874.
4.	Zhu C, Anderson AC, Schubart A, et al. The Tim3 ligand galectin9 negatively regulates T helper type 1 immunity [J]. Nat Immunol, 2005, 6(12): 12451252.
5.	LaBarre DD, Lowy RJ. Improvements in methods for calculating virus titer estimates from TCID50 and plaque assays [J]. J Virol Methods, 2001, 96(2): 107126.
6.	Wada J, Kanwar YS. Identification and characterization of galectin9, a novel βgalactosidebinding mammalian lectin [J]. J Biol Chem, 1997, 272(9): 60786086.
7.	Türeci O, Schmitt H, Fadle N, et al. Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin’s disease [J]. J Biol Chem, 1997, 272(10): 64166422.
8.	楊志明, 伍曉汀, 何濤. Galectin3與腫瘤轉移 [J]. 中國普外基礎與臨床雜志, 2005, 12(3): 310313.
9.	陳耿臻, 韓慧, 許銘炎, 等. ADVtk重組腺病毒的構建及檢測 [J]. 中國普外基礎與臨床雜志, 2010, 17(7): 703706.
10.	曹永寬, 莫永炎, 劉志峰, 等. 人AWP1重組腺病毒的構建及其在人血管內皮細胞中的表達和定位 [J]. 中國普外基礎與臨床雜志, 2009, 16(12): 987990.
11.	韓麗英, 葉明珠, 李荷蓮, 等. 多藥耐藥基因轉染對人胎盤源性間充質干細胞生物學特性影響研究 [J]. 中華醫學雜志, 2009, 89(39): 27932796.
12.	張明滿, 李德華, 茍興華, 等. 靶向肝癌細胞的重組腺相關病毒載體的構建 [J]. 中國普外基礎與臨床雜志, 2005, 12(2): 142146.
13.	陳剛, 韓江, 劉永康, 等. 攜帶IL13基因大鼠肝干細胞系的建立 [J]. 中國普外基礎與臨床雜志, 2009, 16(4): 276280.
14.	Bessis N, GarciaCozar FJ, Boissier MC. Immune responses to gene therapy vectors: influence on vector function and effector mechanisms [J]. Gene Ther, 2004, 11 Suppl 1: S10S17.
15.	Snyder RO, Miao C, Meuse L, et al. Correction of hemophilia B in canine and murine models using recombinant adenoassociated viral vectors [J]. Nat Med, 1999, 5(1): 6470.
16.	Barquinero J, Eixarch H, PérezMelgosa M. Retroviral vectors: new applications for an old tool [J]. Gene Ther, 2004, 11 Suppl 1: S3S9.
17.	Pandori M, Hobson D, Sano T. Adenovirusmicrobead conjugates possess enhanced infectivity: a new strategy for localized gene delivery [J]. Virology, 2002, 299(2): 204212.
18.	Nász I, Adám E. Recombinant adenovirus vectors for gene therapy and clinical trials [J]. Acta Microbiol Immunol Hung, 2001, 48(34): 323348.
19.	Adám E, Nász I. Adenovirus vectors and their clinical application in gene therapy [J]. Orv Hetil, 2001, 142(38): 20612070.
20.	Benihoud K, Yeh P, Perricaudet M. Adenovirus vectors for gene delivery [J]. Curr Opin Biotechnol, 1999, 10(5): 440447.
21.	Morsy MA, Gu M, Motzel S, et al. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene [J]. Proc Natl Acad Sci USA, 1998, 95(14): 78667871.
22.	Gilgenkrantz H, Duboc D, Juillard V, et al. Transient expression of genes transferred in vivo into heart using firstgeneration adenoviral vectors: role of the immune response [J]. Hum Gene Ther, 1995, 6(10): 12651274.
23.	Tripathy SK, Black HB, Goldwasser E, et al. Immune responses to transgeneencoded proteins limit the stability of gene expression after injection of replicationdefective adenovirus vectors [J]. Nat Med, 1996, 2(5): 545550.
24.	He TC, Zhou S, da Costa LT, et al. A simplified system for generating recombinant adenoviruses [J]. Proc Natl Acad Sci USA, 1998, 95(5): 25092514.
25.	Ng P, Parks RJ, Cummings DT, et al. A highefficiency Cre/loxPbased system for construction of adenoviral vectors [J]. Hum Gene Ther, 1999, 10(16): 26672672.

1. Hsu DK, Liu FT. Regulation of cellular homeostasis by galectins [J]. Glycoconj J, 2004, 19(79): 507515.
2. Rabinovich GA, Toscano MA, Ilarregui JM, et al. Shedding light on the immunomodulatory properties of galectins: novel regulators of innate and adaptive immune responses [J]. Glycoconj J, 2004, 19(79): 565573.
3. Wang F, He W, Zhou H, et al. The Tim3 ligand galectin9 negatively regulates CD8+ alloreactive T cell and prolongs survival of skin graft [J]. Cell Immunol, 2007, 250(12): 6874.
4. Zhu C, Anderson AC, Schubart A, et al. The Tim3 ligand galectin9 negatively regulates T helper type 1 immunity [J]. Nat Immunol, 2005, 6(12): 12451252.
5. LaBarre DD, Lowy RJ. Improvements in methods for calculating virus titer estimates from TCID50 and plaque assays [J]. J Virol Methods, 2001, 96(2): 107126.
6. Wada J, Kanwar YS. Identification and characterization of galectin9, a novel βgalactosidebinding mammalian lectin [J]. J Biol Chem, 1997, 272(9): 60786086.
7. Türeci O, Schmitt H, Fadle N, et al. Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin’s disease [J]. J Biol Chem, 1997, 272(10): 64166422.
8. 楊志明, 伍曉汀, 何濤. Galectin3與腫瘤轉移 [J]. 中國普外基礎與臨床雜志, 2005, 12(3): 310313.
9. 陳耿臻, 韓慧, 許銘炎, 等. ADVtk重組腺病毒的構建及檢測 [J]. 中國普外基礎與臨床雜志, 2010, 17(7): 703706.
10. 曹永寬, 莫永炎, 劉志峰, 等. 人AWP1重組腺病毒的構建及其在人血管內皮細胞中的表達和定位 [J]. 中國普外基礎與臨床雜志, 2009, 16(12): 987990.
11. 韓麗英, 葉明珠, 李荷蓮, 等. 多藥耐藥基因轉染對人胎盤源性間充質干細胞生物學特性影響研究 [J]. 中華醫學雜志, 2009, 89(39): 27932796.
12. 張明滿, 李德華, 茍興華, 等. 靶向肝癌細胞的重組腺相關病毒載體的構建 [J]. 中國普外基礎與臨床雜志, 2005, 12(2): 142146.
13. 陳剛, 韓江, 劉永康, 等. 攜帶IL13基因大鼠肝干細胞系的建立 [J]. 中國普外基礎與臨床雜志, 2009, 16(4): 276280.
14. Bessis N, GarciaCozar FJ, Boissier MC. Immune responses to gene therapy vectors: influence on vector function and effector mechanisms [J]. Gene Ther, 2004, 11 Suppl 1: S10S17.
15. Snyder RO, Miao C, Meuse L, et al. Correction of hemophilia B in canine and murine models using recombinant adenoassociated viral vectors [J]. Nat Med, 1999, 5(1): 6470.
16. Barquinero J, Eixarch H, PérezMelgosa M. Retroviral vectors: new applications for an old tool [J]. Gene Ther, 2004, 11 Suppl 1: S3S9.
17. Pandori M, Hobson D, Sano T. Adenovirusmicrobead conjugates possess enhanced infectivity: a new strategy for localized gene delivery [J]. Virology, 2002, 299(2): 204212.
18. Nász I, Adám E. Recombinant adenovirus vectors for gene therapy and clinical trials [J]. Acta Microbiol Immunol Hung, 2001, 48(34): 323348.
19. Adám E, Nász I. Adenovirus vectors and their clinical application in gene therapy [J]. Orv Hetil, 2001, 142(38): 20612070.
20. Benihoud K, Yeh P, Perricaudet M. Adenovirus vectors for gene delivery [J]. Curr Opin Biotechnol, 1999, 10(5): 440447.
21. Morsy MA, Gu M, Motzel S, et al. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene [J]. Proc Natl Acad Sci USA, 1998, 95(14): 78667871.
22. Gilgenkrantz H, Duboc D, Juillard V, et al. Transient expression of genes transferred in vivo into heart using firstgeneration adenoviral vectors: role of the immune response [J]. Hum Gene Ther, 1995, 6(10): 12651274.
23. Tripathy SK, Black HB, Goldwasser E, et al. Immune responses to transgeneencoded proteins limit the stability of gene expression after injection of replicationdefective adenovirus vectors [J]. Nat Med, 1996, 2(5): 545550.
24. He TC, Zhou S, da Costa LT, et al. A simplified system for generating recombinant adenoviruses [J]. Proc Natl Acad Sci USA, 1998, 95(5): 25092514.
25. Ng P, Parks RJ, Cummings DT, et al. A highefficiency Cre/loxPbased system for construction of adenoviral vectors [J]. Hum Gene Ther, 1999, 10(16): 26672672.

《中國普外基礎與臨床雜志》

大鼠galectin-9基因重組腺病毒載體的構建和鑒定

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

《中國普外基礎與臨床雜志》

大鼠galectin-9基因重組腺病毒載體的構建和鑒定

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

摘要全文圖表視頻參考文獻施引文獻補充材料